单位(元)国泰医药健康股票A(009805)利润表 |
报告期 |
2023/12/31 |
2023/6/30 |
2022/12/31 |
2022/6/30 |
收入 |
-54,371,479 |
81,240,401 |
-174,686,681 |
-153,199,318 |
利息收入 |
250,862 |
135,942 |
247,173 |
125,433 |
其中:存款利息收入 |
250,862 |
135,942 |
247,173 |
125,433 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
- |
- |
- |
投资收益 |
-35,913,109 |
44,711,758 |
-211,377,316 |
-118,058,611 |
其中:股票投资收益 |
-53,042,905 |
32,078,248 |
-221,652,601 |
-128,244,029 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
526,809 |
102,492 |
128,661 |
108,210 |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
16,602,988 |
12,531,018 |
10,146,624 |
10,077,208 |
公允价值变动收益 |
-19,326,545 |
35,939,667 |
35,775,519 |
-35,712,998 |
汇兑收益 |
- |
- |
- |
- |
其他收入 |
617,313 |
453,035 |
667,943 |
446,857 |
费用 |
18,218,651 |
10,318,330 |
19,671,496 |
9,975,656 |
管理人报酬 |
14,509,460 |
8,325,004 |
16,403,207 |
8,317,514 |
托管费 |
2,418,243 |
1,387,501 |
2,733,868 |
1,386,252 |
销售服务费 |
1,043,840 |
483,509 |
295,125 |
153,121 |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
247,104 |
122,316 |
239,297 |
118,769 |
利润总额 |
-72,590,130 |
70,922,071 |
-194,358,177 |
-163,174,974 |
减:所得税费用 |
- |
- |
- |
- |
净利润 |
-72,590,130 |
70,922,071 |
-194,358,177 |
-163,174,974 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。